JEVTANA: payments to doctors
Payments that named JEVTANA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.2M
- Providers
- 6,977
- Transactions
- 19,594
- Average per transaction
- $163
The per-transaction average — $163 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,977 providers the average total is $459, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $3,068,667 | 95.9% |
| Sanofi-aventis U.S. LLC | $131,685 | 4.1% |